BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16462762)

  • 1. The synovial sarcoma translocation protein SYT-SSX2 recruits beta-catenin to the nucleus and associates with it in an active complex.
    Pretto D; Barco R; Rivera J; Neel N; Gustavson MD; Eid JE
    Oncogene; 2006 Jun; 25(26):3661-9. PubMed ID: 16462762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation.
    Xie Y; Skytting B; Nilsson G; Gasbarri A; Haslam K; Bartolazzi A; Brodin B; Mandahl N; Larsson O
    Cancer Res; 2002 Jul; 62(13):3861-7. PubMed ID: 12097301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of molecular and cytogenetic findings in synovial sarcoma.
    Panagopoulos I; Mertens F; Isaksson M; Limon J; Gustafson P; Skytting B; Akerman M; Sciot R; Dal Cin P; Samson I; Iliszko M; Ryoe J; Dêbiec-Rychter M; Szadowska A; Brosjö O; Larsson O; Rydholm A; Mandahl N
    Genes Chromosomes Cancer; 2001 Aug; 31(4):362-72. PubMed ID: 11433527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
    Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
    Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusions of the SYT and SSX genes in synovial sarcoma.
    Ladanyi M
    Oncogene; 2001 Sep; 20(40):5755-62. PubMed ID: 11607825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
    Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
    Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SSX1.
    Sun Y; Gao D; Liu Y; Huang J; Lessnick S; Tanaka S
    Oncogene; 2006 Feb; 25(7):1042-52. PubMed ID: 16247461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear beta-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma.
    Saito T; Oda Y; Yamamoto H; Kawaguchi K; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2006 Jun; 37(6):689-97. PubMed ID: 16733209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery.
    Xie Y; Skytting B; Nilsson G; Grimer RJ; Mangham CD; Fisher C; Shipley J; Bjerkehagen B; Myklebost O; Larsson O
    Oncogene; 2002 Aug; 21(37):5791-6. PubMed ID: 12173050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.
    Nilsson G; Skytting B; Xie Y; Brodin B; Perfekt R; Mandahl N; Lundeberg J; Uhlén M; Larsson O
    Cancer Res; 1999 Jul; 59(13):3180-4. PubMed ID: 10397263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
    Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SYT-SSX fusion genes in synovial sarcoma of the thorax.
    Yano M; Toyooka S; Tsukuda K; Dote H; Morimoto Y; Ohata N; Ichimura K; Aoe M; Date H; Shimizu N
    Lung Cancer; 2004 Jun; 44(3):391-7. PubMed ID: 15140553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma.
    Inagaki H; Nagasaka T; Otsuka T; Sugiura E; Nakashima N; Eimoto T
    Mod Pathol; 2000 May; 13(5):482-8. PubMed ID: 10824918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas.
    Yang K; Lui WO; Xie Y; Zhang A; Skytting B; Mandahl N; Larsson C; Larsson O
    Oncogene; 2002 Jun; 21(26):4181-90. PubMed ID: 12037676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A variant of the SYT-SSX2 fusion gene in a case of synovial sarcoma.
    Otsuka S; Nishijo K; Nakayama T; Aoyama T; Ishibe T; Shibata KR; Shima Y; Nakamura T; Otsuka T; Toguchida J
    Cancer Genet Cytogenet; 2006 May; 167(1):82-8. PubMed ID: 16682293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are there geographical differences in the frequency of SYT-SSX1 and SYT-SSX2 chimeric transcripts in synovial sarcoma?
    Koković I; Bracko M; Golouh R; Ligtenberg M; van Krieken HJ; Hudler P; Komel R
    Cancer Detect Prev; 2004; 28(4):294-301. PubMed ID: 15350633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cells.
    Hayakawa K; Ikeya M; Fukuta M; Woltjen K; Tamaki S; Takahara N; Kato T; Sato S; Otsuka T; Toguchida J
    Biochem Biophys Res Commun; 2013 Mar; 432(4):713-9. PubMed ID: 23313505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
    Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
    Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Wnt pathway in synovial sarcoma models.
    Barham W; Frump AL; Sherrill TP; Garcia CB; Saito-Diaz K; VanSaun MN; Fingleton B; Gleaves L; Orton D; Capecchi MR; Blackwell TS; Lee E; Yull F; Eid JE
    Cancer Discov; 2013 Nov; 3(11):1286-301. PubMed ID: 23921231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.